ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity

Lynn D. Condreay; Mathias N. Chiano; Li Li; Elizabeth Harris; Dana J. Fraser; Deborah A. Meyers; Eugene R. Bleecker; Courtney Crim; David Stempel; Steven W. Yancey; Soumitra Ghosh

doi:10.1016/j.jaci.2019.01.012

ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity

Lynn D. Condreay
, Mathias N. Chiano
, Li Li
, Elizabeth Harris
, Dana J. Fraser
, Deborah A. Meyers
, Eugene R. Bleecker
, Courtney Crim
, David Stempel
, Steven W. Yancey
, Soumitra Ghosh

Medicine

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	1962-1965.e4
Journal	Journal of Allergy and Clinical Immunology
Volume	143
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2019.01.012
State	Published - May 2019

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2019.01.012

Cite this

@article{6faa8709cdd243388409197ad114797b,

title = "ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity",

author = "Condreay, \{Lynn D.\} and Chiano, \{Mathias N.\} and Li Li and Elizabeth Harris and Fraser, \{Dana J.\} and Meyers, \{Deborah A.\} and Bleecker, \{Eugene R.\} and Courtney Crim and David Stempel and Yancey, \{Steven W.\} and Soumitra Ghosh",

note = "Funding Information: This pharmacogenetic study was funded by GlaxoSmithKline (United Kingdom) (study nos. 204661, 205064, and 205643). Genetic samples and data were from GlaxoSmithKline studies ADA109055, ADA109057, and HZA106837 (in study 204661), MEA201722 (in study 205064), and MEA122997 and MEA115588 (in study 205643). This study was conceived and implemented by the coauthors and sponsored and funded by GlaxoSmithKline. The protocol, available as part of the online data supplement, was developed in collaboration between the employees of the sponsor and the principal academic investigators. We thank Michael Mosteller, Jonas Daugherty, Ibrahim Raphiou, Pamela St Jean, Joshua Hoffman, and Philip Appleby for consultations in planning and review and statistical analysis assistance. This research has been conducted using data from multiple GlaxoSmithKline-sponsored trials and the UK Biobank Resource under Application Number 26041. We thank all patients who take part in our trials and participants in the UK Biobank study.",

year = "2019",

month = may,

doi = "10.1016/j.jaci.2019.01.012",

language = "English (US)",

volume = "143",

pages = "1962--1965.e4",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity

AU - Condreay, Lynn D.

AU - Chiano, Mathias N.

AU - Li, Li

AU - Harris, Elizabeth

AU - Fraser, Dana J.

AU - Meyers, Deborah A.

AU - Bleecker, Eugene R.

AU - Crim, Courtney

AU - Stempel, David

AU - Yancey, Steven W.

AU - Ghosh, Soumitra

N1 - Funding Information: This pharmacogenetic study was funded by GlaxoSmithKline (United Kingdom) (study nos. 204661, 205064, and 205643). Genetic samples and data were from GlaxoSmithKline studies ADA109055, ADA109057, and HZA106837 (in study 204661), MEA201722 (in study 205064), and MEA122997 and MEA115588 (in study 205643). This study was conceived and implemented by the coauthors and sponsored and funded by GlaxoSmithKline. The protocol, available as part of the online data supplement, was developed in collaboration between the employees of the sponsor and the principal academic investigators. We thank Michael Mosteller, Jonas Daugherty, Ibrahim Raphiou, Pamela St Jean, Joshua Hoffman, and Philip Appleby for consultations in planning and review and statistical analysis assistance. This research has been conducted using data from multiple GlaxoSmithKline-sponsored trials and the UK Biobank Resource under Application Number 26041. We thank all patients who take part in our trials and participants in the UK Biobank study.

PY - 2019/5

Y1 - 2019/5

UR - https://www.scopus.com/pages/publications/85061647020

UR - https://www.scopus.com/pages/publications/85061647020#tab=citedBy

U2 - 10.1016/j.jaci.2019.01.012

DO - 10.1016/j.jaci.2019.01.012

M3 - Article

C2 - 30682460

AN - SCOPUS:85061647020

SN - 0091-6749

VL - 143

SP - 1962-1965.e4

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -

ADRB2 p.Thr164Ile association with hospitalization depends upon asthma severity

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this